Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Marketocracy Masters 100 Fund (MOFQX)

9.14
Net Asset Value
-0.22%
1 Day
+7.40%
Year-to-Date
Overall Morningstar Rating
Mid-cap growth
Style or Category
No Load
Sales Expenses
2.04%
Expense Ratio
Average
Morningstar Risk Rating™
Investment Objective The investment seeks capital appreciation. The fund primarily invests in stocks of U.S. and foreign companies of any size, seeking to outperform the Standard & Poor's 500 Composite Stock Price Index ("S&P 500 Index"). The types of securities in which the fund will generally invest include common stocks, preferred stocks, American Depositary Receipts ("ADRs"), investment companies and exchange traded funds ("ETFs").

Performance

1 month+0.11% 3 years-2.31%
3 months+2.58% 5 years+0.12%
1 year+8.42% Since inception+2.31%
Data through --

Peer Comparisonvs. Mid-cap growth

 MOFQXCategory
Performance 5-yr return+0.12%+10.30%
Expense ratio2.04%1.24%
Risk 5 year sharpe ratio0.010.89
Net assets$3.9M$1.3B
Average market cap$7.3B$10.6B
Average P/E17.127.5
Portfolio turnover219%219%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyMarketocracy Funds
Fund manager & tenureKendrick Kam / 19 Years
Minimal initial investment$10,000.00
Minimum IRA investment--

Holdings

U.S. stock63.55%
Cash26.93%
International stock8.16%
Fixed income1.35%
Other0.01%
Top 5 Sectors
Portfolio weighting
Healthcare 30.41%
Industrial materials 14.05%
Energy 11.81%
Financial service 11.55%
Hardware 8.17%
Top 10 Holdings
Portfolio weighting
HALO Halozyme Therapeutics Inc3.15%
FB Facebook2.94%
NKTR Nektar Therapeutics2.31%
NVDA NVIDIA Corp2.25%
FLXN Flexion Therapeutics Inc2.23%
BLUE bluebird bio Inc1.88%
AMD Advanced Micro Devices Inc1.81%
TRVN Trevena Inc1.80%
GILD Gilead Sciences1.76%
BABA Alibaba Group Holding Ltd1.67%